Comparison of Melanocyte-Associated Immunohistochemical Markers in Acral Lentiginous Melanoma and Acral Benign Nevi
- 1 November 2023
- journal article
- research article
- Published by Wolters Kluwer Health in The American Journal of Dermatopathology
- Vol. 45 (11) , 748-752
Abstract
Acral lentiginous melanoma (ALM) is a relatively rare clinicopathologic subtype of cutaneous malignant melanoma, but it is the most common type of melanoma among Asians. Although the research to identify immunohistochemical (IHC) markers to differentiate nevi from melanoma is being conducted, specific markers for ALM are not well-known. Therefore, we aimed to analyze and compare the differences in the expression of melanocyte-associated IHC markers between ALM and acral benign nevi (ABN). Two independent groups of 53 and 19 paraffin-embedded specimens (from patients with pathologically confirmed ALM and ABN, respectively) were subjected to IHC staining for MART-1, preferentially expressed antigen in melanoma (PRAME), SOX10, HMB-45, Ki-67, and p16. We performed a quantitative analysis of PRAME, SOX10, KI-67, and p16 expression and gradient pattern analysis of HMB-45 expression for each specimen. The PRAME (60.1% and 28.5%, P < 0.05) and Ki-67 (7.8% and 3.5%, P < 0.05) expression levels were significantly higher in the ALM group than in the ABN group. The p16 expression was significantly lower (14.2% and 19.4%, P < 0.05), and the absence of HMB-45 gradient was more frequent in the ALM group than in the ABN group. However, no statistical significance was noted in SOX10 (54.8% and 44.7%). Receiver operating characteristic curves showed that PRAME had the highest area under the curve value. In summary, among various IHC markers, PRAME was the most valuable marker for the diagnosis of ALM; however, further large-scale studies are needed to validate these findings.Keywords
This publication has 23 references indexed in Scilit:
- The BRAAFF checklist: a new dermoscopic algorithm for diagnosing acral melanomaBritish Journal of Dermatology, 2015
- The distribution pattern of HMB‐45‐positive cells is helpful for the diagnosis of early acral lentiginous melanoma in situInternational Journal of Dermatology, 2015
- Comparison of Melanoma Subtypes among Korean Patients by Morphologic Features and Ultraviolet ExposureAnnals of Dermatology, 2014
- SOX10 Expression in Malignant Melanoma, Carcinoma, and Normal TissuesApplied Immunohistochemistry & Molecular Morphology, 2013
- Clinical presentation, histology, and prognoses of malignant melanoma in ethnic Chinese: A study of 522 consecutive casesBMC Cancer, 2011
- Use of immunohistochemistry in melanocytic lesionsJournal of Cutaneous Pathology, 2008
- Statistical profiles of malignant melanoma and other skin cancers in Japan: 2007 updateInternational Journal of Clinical Oncology, 2008
- Early Acral Melanoma In SituThe American Journal of Dermatopathology, 2006
- Pax3 is required for enteric ganglia formation and functions with Sox10 to modulate expression of c-retJournal of Clinical Investigation, 2000
- Nevoid malignant melanoma: morphologic patterns and immunohistochemical reactivityJournal of Cutaneous Pathology, 1995